iDECIDE: A Mobile Application for Insulin Dosing Using an Evidence Based Equation to Account for Patient Preferences.

Diabetes is a complex disease affecting 29.1 million (9.3%) US citizens [1]. It is a chronic illness that needs continual medical care and ongoing patient self-management, education, and support [2]. There is no cure for diabetes, requiring patients to conduct frequent self-monitoring of blood glucose and dosing of insulin in many cases. Evidence has shown that patients are more adherent to their diabetes management plan when they incorporate personal lifestyle choices [3]. To address the challenge of empowering patients to better manage their diabetes, we have developed a novel mobile application prototype, iDECIDE, that refines rapid-acting insulin dose calculations by incorporating two important patient variables in addition to carbohydrates consumed that are not a part of standard insulin dose calculation algorithms: exercise and alcohol intake [4, 5]. A retrospective analysis for the calibration and evaluation of iDECIDE is underway by comparing recommendations made by the application against dosing recommendations made by insulin pumps.